Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





US COVID-19 Testing Supply Data Reveal One Million Tests Being Shipped Per Day

By LabMedica International staff writers
Posted on 31 Jul 2020
Data released by a US national COVID-19 diagnostic supply registry shows that over one million SARS-CoV-2 tests are being shipped every day.

The national registry has been created by the Advanced Medical Technology Association (AdvaMed Washington, D.C., USA) in partnership with 13 commercial diagnostics manufacturers: Abbott, BD, bioMérieux, Bio-Rad, Beckman Coulter, Cepheid, Hologic, Ortho Clinical Diagnostics, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. More...
The tests offered by these 13 leading diagnostic manufacturers together comprise ~95% of the COVID-19 tests on the market in the US. AdvaMed is also working closely with the White House, HHS, FDA, FEMA and other key government agencies to ensure the continued supply of diagnostics tests, as well as other vital medical equipment such as PPE and ventilators, in the fight against the COVID-19 pandemic.

According to key data of the US COVID testing supply released by AdvaMed, over100 commercial tests for COVID-19 have secured authorization by the US FDA. Across leading COVID diagnostic manufacturers, roughly 80 million molecular COVID-19 tests have been manufactured and shipped since March. Manufacturers have increased molecular test production from about 450,0001 shipments per day at the start of May to over 870,0001 shipments per day by July 18. The past week’s shipping patterns show an all-time weekly high of one million tests shipped per day.

As per public sources, daily molecular test runs continue to grow rapidly as well, increasing by ~30% to date in July vs. June’s average, reaching an all-time peak of about 775,000 tests per day by mid-July. High-quality serology testing, authorized by the FDA, is now available at scale with industry capacity to manufacture 100 million tests per month.

Related Links:
Advanced Medical Technology Association (AdvaMed)


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.